002261:SZSETalkweb Information System Co.,Ltd. Analysis
Data as of 2026-06-14 - not real-time
CN¥29.81
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Talkweb is trading at CNY 29.81, well below its 20‑day (≈30.80), 50‑day (≈33.88) and 200‑day (≈34.30) moving averages, signaling a bearish price environment. The RSI sits near 44, indicating neutral momentum, while the MACD histogram is modestly positive, giving a slight bullish signal that is unlikely to overcome the broader downtrend. Valuation metrics are extreme: a trailing P/E of roughly 596 versus an industry average of 37, a forward P/E of about 157, and a DCF‑derived fair value of only CNY 3.8, all pointing to severe overvaluation. Revenue has contracted by 4.7% YoY, margins are thin (gross ~15%, operating ~9%, net ~2%) and ROE languishes at just 1.35%, underscoring weak profitability. Despite a solid cash position (≈CNY 1.13 bn) the company carries a high debt‑to‑equity ratio of over 14, raising balance‑sheet concerns. Volatility is elevated at nearly 60% over 30 days, though beta is low (~0.16), indicating limited systematic risk but high idiosyncratic swings. Regulatory scrutiny on Chinese tech firms adds an additional layer of uncertainty, while the absence of any dividend further diminishes income appeal. Overall, the stock appears significantly overvalued with limited growth traction, making it a risky holding in the near term.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Extreme P/E relative to industry
- Bearish technical positioning below key moving averages
- Declining revenue and thin profit margins
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong cash buffer offsetting high debt
- Low beta limiting market‑wide volatility exposure
- Uncertainty around Chinese tech regulatory environment
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Potential strategic shift toward AI and digital platforms
- Persistently high valuation multiples
- Elevated leverage and modest return on equity
Key Metrics & Analysis
Financial Health
Revenue Growth-4.70%
Profit Margin1.91%
P/E Ratio596.2
ROE1.35%
ROA0.63%
Debt/Equity14.23
P/B Ratio14.4
Op. Cash FlowCN¥476.5M
Free Cash FlowCN¥307.5M
Industry P/E36.8
Technical Analysis
TrendBearish
RSI44.3
SupportCN¥26.65
ResistanceCN¥34.69
MA 20CN¥30.80
MA 50CN¥33.88
MA 200CN¥34.30
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Fair ValueCN¥3.82
GradeOvervalued
TypeValue
Risk Assessment
Beta0.16
Volatility59.40%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.